During the past decade, Wojewodzki Szpital Specjalistyczny we Wroclawiu conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 16 clinical trials were completed, i.e. on average, 84.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny we Wroclawiu" #1 sponsor was "Actelion" with 8 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Ipsen" with 2 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny we Wroclawiu" #1 collaborator was "ActiGraph LLC" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Almac Clinical Technologies" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "Henry Ford Health System" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Specjalistyczny we Wroclawiu" are "Arthritis, Rheumatoid" (4 trials), "Chronic Thromboembolic Pulmonary Hypertension" (3 trials), "Hypertension, Pulmonary" (3 trials), "Rheumatoid Arthritis" (3 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Wojewodzki Szpital Specjalistyczny we Wroclawiu" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Specjalistyczny we Wroclawiu" are "Drug" (23 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Selexipag" (3 trials), "Apaziquone" (2 trials), "BI 695501" (2 trials) and "GLPG0634" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Specjalistyczny we Wroclawiu" are 25 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Specjalistyczny we Wroclawiu". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Wojewodzki Szpital Specjalistyczny we Wroclawiu, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Specjalistyczny we Wroclawiu, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Wojewodzki Szpital Specjalistyczny we Wroclawiu has several departments that took part in Clinical trials: "Wojewodzki Szpital Specjalistyczny, Oddzial Kardiologiczny" - 4 trials, "Oddzial Dermatologiczny" - 2 trials